sterile

Challenges and Innovation in Sterile Manufacturing

April Stanley, MS MBA

Nice Insight

MPS

What Will It Take for Organ-on-Chip Data to Replace Animal Studies?

David Alvaro, Ph.D.

Pharma's Almanac

antibodies

Key Technologies Used in Manufacturing Antibodies

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

OSD

Oral Solid Dose Manufacturing Basics

April Stanley, MS MBA

Nice Insight

OSD

Advanced Oral Solid Dose Manufacturing Technologies

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

sterile / market

Foundations of the Sterile Injectable Drugs Market

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

OSD

Introduction to Oral Solid Dose

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Genome Engineering

Aiming for More than Single-Base Corrections: The Technologies Opening the Genome to Therapeutic Cargo

David Alvaro, Ph.D.

Pharma's Almanac

Organoids

Building Bioreactors for Living Architecture: The Manufacturing Challenge for Clinical-Grade Organoids

David Alvaro, Ph.D.

Pharma's Almanac

Cell-Free Synthesis

Cell-Free Biomanufacturing and the Future of Flexible Biologics Production

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

CGT Patents

The Patent Landscape and its Implications: Cell and Gene Therapies

April Stanley, MS MBA

Nice Insight

Biomanufacturing

Biomanufacturing with E. coli

April Stanley, MS MBA

Nice Insight

Biologics Patents

The Patent Landscape and its Implications: Biologics and ADCs

April Stanley, MS MBA

Nice Insight

Self-Healing

Beyond Cleaning: Could Self-Healing Materials Redefine Bioprocess Surfaces?

David Alvaro, Ph.D.

Pharma's Almanac

NGIB

Rethinking Fermentation: Halophiles and the Next Generation of Industrial Biotechnology

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Single-Use vs. Stainless-Steel Bioreactors: Which Manufacturing Platform Is Better for Biopharmaceutical Production?

Nice Insight

Pathfinder

AAV vs. Non-Viral Gene Delivery: Which Is Better for In Vivo Gene Therapy?

Nice Insight

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight